HomeSAN • EPA
add
Sanofi SA
Nakaraang pagsara
€90.87
Sakop ng araw
€91.56 - €93.24
Sakop ng taon
€83.28 - €106.14
Market cap
117.80B EUR
Average na Volume
1.52M
P/E ratio
25.92
Dividend yield
4.04%
Primary exchange
EPA
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 14.16B | 11.49% |
Gastos sa pagpapatakbo | 5.99B | 11.39% |
Net na kita | 2.82B | 11.49% |
Net profit margin | 19.88 | -0.05% |
Kita sa bawat share | 1.54 | -39.43% |
EBITDA | 4.91B | 15.96% |
Aktuwal na % ng binabayarang buwis | 20.58% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 6.80B | -14.99% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 73.00B | — |
Natitirang share | 1.25B | — |
Presyo para makapag-book | 1.56 | — |
Return on assets | — | — |
Return on capital | 10.54% | — |
Cash Flow
Net change in cash
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 2.82B | 11.49% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
CEO
Itinatag
1973
Headquarters
Website
Mga Empleyado
86,088